Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (16857)	5/11/2004 7:57:17 PM
From: Cacaito	Read Replies (2) \| Respond to of 17367

xoma to sell Raptiva royalties to "investors"...Top that!!! Forget Raptiva $6.2 millions in sales (Gw, Dna reported that long ago), or the $0.2M REVENUES !!! How much does xoma gets from Alexion? Top (Alex needs xoma's antibody technology, nothing new, and xoma will give it up for nothing new)! Well, let's be optimistic, Amgen could not figure out the platelets business cause they were so smart that they gave it to healthy subjects to create lots for the transfusion business, then the subject got thrombosis, and then the Fda said folgedaaboudid! Now, Alex the big one comes to the rescue, kind of let's give it to the people who needs it in the first place the ones with low platelets, better for the chemotherapy ones cause you know the cause and they take a while before bleeding and then one has some time to kick in with an stimulating mab (xoma give the engineering, Alex the receptor, and alex gets the money...oops, I did it again, could not stay positve one second... xoma also gets some money...like pdli and tnox do from CLEAN royalties, not bad (for pdli and tnox), But, not for xoma, logic is not working (even Gw short is working): ...Then xoma to finance the Top, will sell the Raptiva royalties to some "investors", a good business, since they will get $12M for the 25%, brilliant! ING1 officially dead, sorry Rk.

To: Bluegreen who wrote (16857)	5/12/2004 10:40:18 AM
From: aknahow	Read Replies (4) \| Respond to of 17367

A mining company tells you where they are going to drill. Projected depth. When drilling will begin. The assay results when submitted to the company. A biotech company does not need to tell you what they are doing, nor when they will start doing what they have not told you, nor when they are thru doing it, nor what the results were. What starts out as a core project gets reversed into a probe. Then when and if a product is approved, a biotech does not need to tell you how much actual sales are. But investors keep buying the stock. Should one blame a company like Xoma, or the ones that keep buying it even when the information flow does not permit making an informed decision?

To: Bluegreen who wrote (16857)	5/20/2004 10:16:43 PM
From: Edscharp	Read Replies (1) \| Respond to of 17367

Bluegreen? Is it really you? What happened? How did you escape from the Xoma Matrix which was intended to keep your mind in a prison that you could not see, nor hear, nor touch? What modern day Morpheus saved you? And, why oh why did you take the 'blue' pill? Your recent negative posts exceed the combined skepticism of all my previous posts put together. Is this a short term play for you? Or, are you just biding your time waiting for Clearasil-Neuprex to rear up on it's ugly haunches. lol. Enquiring investors want to know.